Skip to main content
ArticleOPEN ACCESS

Vertical disintegration: A strategy for pharmaceutical businesses in 2009?

Nature Reviews Drug Discovery
DOI: 10.1038/nrd2914
12Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Enhancing the productivity of drug R&D might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations.

Cite

CITATION STYLE

APA

Dixon, J., Lawton, G., & Machin, P. (2009). Vertical disintegration: A strategy for pharmaceutical businesses in 2009? Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd2914

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free